Två artiklar publicerade i The Lancet

This page in English

Grattis Professor Mark Maeurer och hans grupp på avdelningen för Terapeutisk immunologi (TIM), som tillsammans med deras samarbetspartners på UNZA, fick två artiklar publicerade i The Lancet den 21 mars.

Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers

Robert S Wallis, Markus Maeurer, Peter Mwaba, Jeremiah Chakaya, Roxana Rustomjee, Giovanni Battista Migliori, Ben Marais, Marco Schito, Gavin Churchyard, Soumya Swaminathan, Michael Hoelscher, Alimuddin Zumla
The Lancet Infectious Diseases, Volume 16, No. 4, e34–e46, April 2016

Host-directed therapies for infectious diseases: current status, recent progress, and future prospects

Alimuddin Zumla, Martin Rao, Robert S Wallis, Stefan H E Kaufmann, Roxana Rustomjee, Peter Mwaba, Cris Vilaplana, Dorothy Yeboah-Manu, Jeremiah Chakaya, Giuseppe Ippolito, Esam Azhar, Michael Hoelscher, Markus Maeurer, for Host-Directed Therapies Network consortium. The Lancet Infectious Diseases, Volume 16, No. 4, e47–e63, April 2016